NeuroQuant 2.0 Just Got Better

Cortechs.ai | NeuroQuant 2.0 Just Got Better3 New Reports Available With NeuroQuant 2.0

Familiarize yourself with our three brand new NeuroQuant reports – Multi Structure Atrophy, Triage Brain Atrophy, and Brain Development Reports.

Multi Structure Atrophy Report 

  • Helpful in an atrophied brain with a high lesion burden, such as is seen in forms of Multiple Sclerosis and age associated neurodegenerative conditions.
  • Gives total brain volume, white and gray matter, thalamus and more measurements compared to age and gender matched norms.
  • Designated Report Color – Green
  • Easy recognition of reports sorted by color

Triage Brain Report

  • Multiple volume measurements sorted by lobe and brain structure sub-regions affected by trauma
  • Indicates right and left values for Z-score and normative percentile of ICV of 39 brain structures
  • Designated Report Color – Red
  • Easy recognition of reports sorted by color

Brain Development Report

  • Helpful in the assessment of pediatric brain development
  • Forebrain parenchyma and lateral ventricles for age norms 3 and up
  • Designated Report Color – Purple
  • Easy recognition of reports sorted by color

Want to learn even more about NeuroQuant 2.0? Click here to read more about NeuroQuant 2.0 features and benefits or register below to watch the following webinars:

  1. Familiarize Yourself with NeuroQuant 2.0, hosted by Chris Airriess, Chief Technology Officer, Cortechs.ai – June 11th
  2. NeuroQuant 2.0 for Neurodegenerative Assessment,hosted by Dr. James Brewer, UC San Diego – June 17th

More Resources

09/30/2026

Today’s Examination Becomes Tomorrow’s Baseline: The Benefits of Performing Quantitative Analysis on Every Brain MRI

A single brain MRI shows where a patient is today. A quantitative baseline can help show how the brain changes over time.

09/18/2026

What a Head CT Can and Can’t Tell You About a Concussion

For Concussion Awareness Day, learn how quantitative CT analysis can help measure subtle structural changes and support follow-up after traumatic brain injury.

09/09/2026

Prostate Cancer Awareness Month: Finding the Cancer That Matters

How quantitative MRI can bring greater clarity to decisions across the prostate cancer journey.

09/01/2026

Quantifying What Matters: Advancing Alzheimer’s Imaging with NeuroQuant®

Explore how quantitative imaging is transforming Alzheimer’s care, from structural volumetrics and amyloid PET to treatment monitoring with NeuroQuant®.

08/19/2026

Brain Metastases Imaging Insights from SNO/ASCO 2026

Explore key insights from SNO/ASCO 2026 on brain metastases imaging, including lesion tracking, volumetric analysis, SRS workflows, and automated segmentation.

08/18/2026

Cortechs.ai Announces FDA Clearance for NeuroQuant® PET: Advancing Molecular Imaging for Cognitive Impairment

NeuroQuant® PET receives FDA 510(k) clearance, advancing quantitative PET imaging for cognitive impairment.
Scroll to Top